Optometry

Orasis Pharmaceuticals Announces FDA Approval of QLOSI™ (pilocarpine hydrochloride ophthalmic solution) 0.4% for the Treatment of Presbyopia

Retrieved on: 
Wednesday, October 18, 2023

QLOSI is expected to be commercially available in the U.S. in the first half of 2024.

Key Points: 
  • QLOSI is expected to be commercially available in the U.S. in the first half of 2024.
  • "The FDA approval of QLOSI marks a tremendous milestone for Orasis as we continue our mission to provide a flexible treatment option for the millions of people in the U.S. living with presbyopia, or blurry near vision," said Elad Kedar, Chief Executive Officer of Orasis Pharmaceuticals.
  • "I am grateful to the Orasis team, our strategic partners, clinical investigators, and patients who participated in our clinical trials, all of whom made this achievement possible."
  • QLOSI (pronounced CLOH-see) is a prescription eye drop that can be used daily, or as needed, up to twice per day.

VTI Announces Positive Interim 1-Year Data from the PROTECT Clinical Trial at American Academy of Optometry Annual Meeting

Retrieved on: 
Thursday, October 12, 2023

Visioneering Technologies, Inc. (ASX:VTI), producer of the NaturalVue® Multifocal 1 Day Contact Lenses, presented interim data from the PROTECT Clinical Trial at the American Academy of Optometry's annual meeting.

Key Points: 
  • Visioneering Technologies, Inc. (ASX:VTI), producer of the NaturalVue® Multifocal 1 Day Contact Lenses, presented interim data from the PROTECT Clinical Trial at the American Academy of Optometry's annual meeting.
  • Interim 1-year data from the PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) clinical trial, conducted across four countries, demonstrated the safety and effectiveness of NaturalVue Multifocal (“NVMF”) contact lenses in controlling myopia progression in pediatric patients.
  • Over 12 months, the treatment effect yielded a 69% (0.41Diopter) reduction in refractive error compared to the control group.
  • We're thrilled to unveil the 1-year interim results of our PROTECT RCT, demonstrating the effectiveness of NaturalVue Multifocal in managing myopia in children."

NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs

Retrieved on: 
Wednesday, October 11, 2023

Through the new Avenova Loyalty Program and Avenova Affiliate Program, top Avenova eyecare professionals will have access to special promotions specifically designed to increase the awareness of the full suite of Avenova products.

Key Points: 
  • Through the new Avenova Loyalty Program and Avenova Affiliate Program, top Avenova eyecare professionals will have access to special promotions specifically designed to increase the awareness of the full suite of Avenova products.
  • “We have thousands of eye care professionals who recommend, prescribe, and sell our Avenova spray on a daily basis.
  • 1 doctor-recommended lid and lash cleanser and we are delighted to offer these partnership opportunities to grow this important sales channel,” said Justin Hall, CEO of NovaBay Pharmaceuticals.
  • Ophthalmologists and optometrists interested in learning more about the new Avenova Loyalty and Affiliate Programs should email [email protected] or call 510-899-8841.

Dry Eye Foundation Launches New Eye Drop Lookup Tool

Retrieved on: 
Thursday, October 12, 2023

NEW ORLEANS, Oct. 12, 2023 /PRNewswire/ -- Dry Eye Foundation announced the launch of an easy-to-search eye drop database called "Are My Eye Drops Safe?" today during the American Academy of Optometry's annual meeting. Health care professionals and consumers can use this tool to find detailed information on over-the-counter eye drops sold in the US, including illegally marketed products, recalled products, and products subject to FDA safety communications or warnings.

Key Points: 
  • NEW ORLEANS, Oct. 12, 2023 /PRNewswire/ -- Dry Eye Foundation announced the launch of an easy-to-search eye drop database called "Are My Eye Drops Safe?"
  • "We built this tool to help get people access to real-time information on eye drop safety and cut through the confusion."
  • The Dry Eye Foundation is a 501(c)(3) nonprofit organization based in Poulsbo, Washington.
  • Dry Eye Foundation is working to restore hope, redefine disease and reshape the future for people with these conditions, through its community service, education, research and advocacy programs.

75% of Vision Loss Is Preventable and Treatable, but Half of Canadians Don't Know It

Retrieved on: 
Thursday, October 12, 2023

"The survey showed that most Canadians are unaware that most vision loss is preventable and treatable.

Key Points: 
  • "The survey showed that most Canadians are unaware that most vision loss is preventable and treatable.
  • The Survey showed over one-third of Canadians (35 per cent) would only book an eye exam if they experienced vision issues.
  • Catching eye diseases early through a comprehensive eye exam allows for preventative measures to maintain as much vision as possible.
  • What many don't know is that often eye diseases, such as glaucoma, progress without symptoms in the early stages.

SightMD Welcomes Reena Patel, OD to its expert team in New York

Retrieved on: 
Monday, October 9, 2023

HAUPPAUGE, N.Y., Oct. 9, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Reena Patel, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Reena Patel, OD to its expert team.
  • HAUPPAUGE, N.Y., Oct. 9, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Reena Patel, OD to its expert team.
  • Dr. Reena Patel is a board certified Optometric physician who is committed to providing the highest level of care for all her patients.
  • Dr. Patel earned her Bachelor of Science degree in Optometry and Visual Science from City University London.

Registered Nurses & Health Care Workers Launch Five-Day Strike Against Prime's St. Francis Medical Center Starting on October 9

Retrieved on: 
Sunday, October 8, 2023

LOS ANGELES, Oct. 8, 2023 /PRNewswire/ -- Nearly all essential medical personnel at St. Francis Medical Center will walk out at 6:30 a.m. on Monday, October 9, to join the strike lines against Prime Healthcare (which owns hospitals in fourteen states), where they will march, picket, and chant for five days to protest chronically dangerous short staffing and patient care practices, along with unfair labor practices such as bad faith bargaining, threats, and attacks on workers' rights.

Key Points: 
  • 2017 – 2019 – RN turnover at St. Francis was 24.01%
    2020 – 2022 – RN turnover at St. Francis more than doubled to 50.42%
    The average replacement cost of one RN is $46,000.
  • The striking workers include 600 registered nurses represented by UNAC/UHCP and 900 other health care workers represented by SEIU-UHW: nursing assistants, medical assistants, vocational nurses, emergency room technicians, respiratory therapists, environmental services aides, and more.
  • St. Francis Medical Center is one of the busiest hospitals in Los Angeles County, with the only level II trauma, stroke, and STEMI center for many miles around.
  • Registered Nurses and allied health care workers strike St. Francis Medical Center
    Strikers return to work at 6:30 a.m. Saturday, October 14
    3630 E. Imperial Hwy, Lynwood, CA 90262 Imperial Highway & Martin Luther King, Blvd
    Hundreds of nurses and other health care workers in scrubs, uniforms, union gear, with allies, marching and chanting with picket signs
    Note for morning shows: Nurses will be available for live interviews beginning around 6:30 a.m.

Easy Blink Optometry Announces Vision Therapy Services to Address Eye Health

Retrieved on: 
Tuesday, October 3, 2023

Calgary, Alberta--(Newsfile Corp. - October 3, 2023) - Easy Blink Optometry, a leading vision therapy service provider in Calgary, Alberta, Canada is proud to unveil vision therapy services to address eye health problems affecting one's daily life.

Key Points: 
  • Calgary, Alberta--(Newsfile Corp. - October 3, 2023) - Easy Blink Optometry, a leading vision therapy service provider in Calgary, Alberta, Canada is proud to unveil vision therapy services to address eye health problems affecting one's daily life.
  • Easy Blink Optometry's range of services includes vision therapy, eye examination, dry eye care, specialty eye care, emergency eye care, lens fitting & eyeglasses, and many more.
  • Easy Blink Optometry's dedication to excellence in providing vision therapy and personalized eye care makes them a leading specialist in vision therapy in Alberta.
  • As a vision therapy specialist in South West Calgary, Easy Blink Optometry ensures accurate eye care diagnoses, personalized optometry treatments, and exceptional patient experience tailored to their unique needs.

PlenOptika's QuickSee Free wins Silmo D'Or prize in Material & Equipment

Retrieved on: 
Monday, October 2, 2023

CAMBRIDGE, Mass., Oct. 2, 2023 /PRNewswire/ -- QuickSee Free, a new handheld wavefront aberrometry-powered autorefractor from PlenOptika , was named winner in the Material & Equipment category of the 30th SILMO D'Or awards in Paris on Saturday, September 30.

Key Points: 
  • CAMBRIDGE, Mass., Oct. 2, 2023 /PRNewswire/ -- QuickSee Free, a new handheld wavefront aberrometry-powered autorefractor from PlenOptika , was named winner in the Material & Equipment category of the 30th SILMO D'Or awards in Paris on Saturday, September 30.
  • "This is a reward for a lot of innovation and work," said Rodolphe Tessé, President of Saargos, PlenOptika's distribution partner in France.
  • QuickSee Free is PlenOptika's new medical device designed to make accurate objective refraction measurements—the critical for accurate eyeglass and contact lens prescriptions—more accessible.
  • The SILMO D'Or Prizes are given each year at the SILMO international optics and eyewear exhibition, which is attended by more than 34,000 people.

SightMD Welcomes Taylor Rado, OD to its expert team in New York

Retrieved on: 
Monday, October 2, 2023

HAUPPAUGE, N.Y., Oct. 2, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Taylor Rado, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Taylor Rado, OD to its expert team.
  • HAUPPAUGE, N.Y., Oct. 2, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Taylor Rado, OD to its expert team.
  • Dr. Taylor Rado is a board certified optometrist who enjoys providing comprehensive eye care, fitting contact lenses, and managing post-op care in collaboration with the other providers at SightMD.
  • She then went on to complete her Doctor of Optometry degree at the New England College of Optometry in Boston, Massachusetts.